Cover Image
市場調查報告書

手術用縫合線:開發中產品分析

Surgical Sutures - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 334923
出版日期 內容資訊 英文 101 Pages
訂單完成後即時交付
價格
Back to Top
手術用縫合線:開發中產品分析 Surgical Sutures - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年07月01日 內容資訊: 英文 101 Pages
簡介

本報告提供目前開發中的手術用縫合線的開發中產品資訊調查分析,提供您主要產品·計劃,主要企業,臨床實驗資訊,最近的趨勢等相關的系統性資訊。

第1章 目錄

第2章 簡介

  • 手術用縫合線概要

第3章 開發中的產品

  • 手術用縫合線 - 開發中產品:各開發階段
  • 手術用縫合線 - 開發中產品:各市場區隔
  • 手術用縫合線 - 開發中產品:各地區
  • 手術用縫合線 - 開發中產品:各法規途徑
  • 手術用縫合線 - 開發中產品:各核準時期 (預定)

第4章 手術用縫合線:正在開發的開發中產品 (各企業)

  • 手術用縫合線企業 - 開發中產品:各開發階段
  • 手術用縫合線 - 開發中產品:各開發階段

第5章 手術用縫合線企業與產品概要

  • Advanced Medical Solutions Group plc
  • Advanced Suture
  • BioSurfaces, Inc.
  • Ligadon
  • Mellon Medical B.V.
  • Meta Biomed Co., Ltd.
  • Tepha, Inc.
  • The Johns Hopkins University
  • TissueGen, Inc.
  • Universidade Nova de Lisboa

第6章 手術用縫合線:最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's Medical Devices sector report, "Surgical Sutures - Medical Devices Pipeline Assessment, 2017" provides an overview of Surgical Sutures currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Surgical Sutures pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Surgical Sutures under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Surgical Sutures and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Surgical Sutures under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Surgical Sutures Overview 6

3 Products under Development 7

  • 3.1 Surgical Sutures - Pipeline Products by Stage of Development 7
  • 3.2 Surgical Sutures - Pipeline Products by Segment 8
  • 3.3 Surgical Sutures - Pipeline Products by Territory 9
  • 3.4 Surgical Sutures - Pipeline Products by Regulatory Path 10
  • 3.5 Surgical Sutures - Pipeline Products by Estimated Approval Date 11
  • 3.6 Surgical Sutures - Ongoing Clinical Trials 12

4 Surgical Sutures - Pipeline Products under Development by Companies 13

  • 4.1 Surgical Sutures Companies - Pipeline Products by Stage of Development 13
  • 4.2 Surgical Sutures - Pipeline Products by Stage of Development 14

5 Surgical Sutures Companies and Product Overview 15

  • 5.1 Ethicon US LLC Company Overview 15
    • 5.1.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.2 Innovation Pharmaceuticals Inc Company Overview 21
    • 5.2.1 Innovation Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.3 John Hopkins University Company Overview 22
    • 5.3.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.4 MiMedx Group Inc Company Overview 23
    • 5.4.1 MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.5 Nobles Medical Technology, Inc. Company Overview 24
    • 5.5.1 Nobles Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.6 NuVascular Technologies Inc Company Overview 25
    • 5.6.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.7 Resorba GmbH Company Overview 26
    • 5.7.1 Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.8 Silver Bullet Therapeutics, Inc. Company Overview 29
    • 5.8.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.9 Tepha Inc Company Overview 30
    • 5.9.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.10 The University of North Carolina at Chapel Hill Company Overview 31
    • 5.10.1 The University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.11 TissueGen Inc Company Overview 32
    • 5.11.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.12 VitaThreads, LLC Company Overview 33
    • 5.12.1 VitaThreads, LLC Pipeline Products & Ongoing Clinical Trials Overview 33

6 Surgical Sutures - Recent Developments 34

  • 6.1 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 34
  • 6.2 Jun 07, 2017: Cellceutix Announces Company Name Change to Innovation Pharmaceuticals 34
  • 6.3 May 31, 2017: Depuy Synthes and Ethicon to Showcase Intra Operative Solutions Aiming to Mitigate Surgical Site Infection During Efort Congress 35
  • 6.4 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 36
  • 6.5 May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures 39
  • 6.6 Apr 28, 2017: MiMedx Announces Record Results For First Quarter Of 2017 40
  • 6.7 Apr 26, 2017: CONMED Announces First Quarter 2017 Financial Results 42
  • 6.8 Apr 13, 2017: MiMedx Announces First Quarter 2017 Revenue to Exceed High End of Guidance 43
  • 6.9 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 44
  • 6.10 Mar 31, 2017: B. Braun continues its sales and earnings growth 44
  • 6.11 Mar 19, 2017: MiMedx Announces The Addition Of Luis A. Aguilar To Its Board Of Directors 46
  • 6.12 Mar 14, 2017: Advanced Medical Solutions Group: Unaudited preliminary Results for the year ended 31 December 2016 47
  • 6.13 Mar 14, 2017: Arthrex Welcomes Mark Ferguson, MD, as Director of Medical Education, Asia-Pacific (APAC) Region 48
  • 6.14 Feb 23, 2017: MiMedx Announces 2016 Record Results 49
  • 6.15 Feb 22, 2017: Change in the B. Braun Management Board 51
  • 6.16 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 51
  • 6.17 Feb 16, 2017: Cellceutix Reports on Q2 Fiscal 2017, Prepares for Important Clinical Milestones 54
  • 6.18 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 56
  • 6.19 Feb 01, 2017: CONMED Announces Fourth Quarter and Fiscal Year 2016 Financial Results 56
  • 6.20 Feb 01, 2017: CROMA-PHARMA opens 12th subsidiary in Germany 58
  • 6.21 Jan 09, 2017: MiMedx Fourth Quarter 2016 Revenue in Upper Range of Guidance 58
  • 6.22 Dec 16, 2016: MiMedx 2017 Guidance Forecasts Revenue Growth In Excess Of 21% And Operating Earnings Growth In Excess Of 90% 60
  • 6.23 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 61
  • 6.24 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 64
  • 6.25 Nov 14, 2016: Cellceutix Provides Corporate Update and Reports Q1 Fiscal 2017 Financial Results 64
  • 6.26 Nov 03, 2016: MiMedx Announces USP-NF Monograph For dHACM Allografts Has Published 68
  • 6.27 Oct 27, 2016: MiMedx Announces Third Quarter 2016 Results 69
  • 6.28 Oct 27, 2016: CONMED Announces Third Quarter 2016 Financial Results 72
  • 6.29 Oct 10, 2016: MiMedx Third Quarter 2016 Revenue Exceeds Upper End of Guidance 73
  • 6.30 Sep 16, 2016: Cellceutix Announces Appointment of Vice President for Regulatory Affairs 74
  • 6.31 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 75
  • 6.32 Sep 14, 2016: Advanced Medical Solutions Group: Interim Results for the six months ended 30 June 2016 76
  • 6.33 Sep 13, 2016: Cellceutix Provides Business Update and Timeline of Upcoming Milestones 84
  • 6.34 Sep 06, 2016: MiMedx Reaffirms Q3 and Full Year 2016 Guidance 85
  • 6.35 Aug 30, 2016: Cellceutix Further Expands Its Senior Management Team With the Addition of an Industry Veteran 85
  • 6.36 Aug 30, 2016: Cellceutix Further Expands Its Senior Managment Team With the Addition of an Industry Veteran 86
  • 6.37 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 86
  • 6.38 Jul 27, 2016: CONMED Announces Second Quarter 2016 Financial Results 89
  • 6.39 Jul 26, 2016: MiMedx Announces Second Quarter 2016 Results 90
  • 6.40 Jul 11, 2016: MiMedx Second Quarter Of 2016 Revenue Exceeds Upper End Of Guidance Range 94
  • 6.41 Jul 07, 2016: MiMedx Adds New Executive 95
  • 6.42 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 96
  • 6.43 Jun 30, 2016: Cellceutix Announces Industry Veteran Arthur P. Bertolino, MD, PhD, MBA Joins Company as President and Chief Medical Officer 96

7 Appendix 98

  • 7.1 Methodology 98
  • 7.2 About GlobalData 101
  • 7.3 Contact Us 101
  • 7.4 Disclaimer 101

List of Tables

1.1 List of Tables

  • Table 1: Surgical Sutures - Pipeline Products by Stage of Development 7
  • Table 2: Surgical Sutures - Pipeline Products by Segment 8
  • Table 3: Surgical Sutures - Pipeline Products by Territory 9
  • Table 4: Surgical Sutures - Pipeline Products by Regulatory Path 10
  • Table 5: Surgical Sutures - Pipeline Products by Estimated Approval Date 11
  • Table 6: Surgical Sutures - Ongoing Clinical Trials 12
  • Table 7: Surgical Sutures Companies - Pipeline Products by Stage of Development 13
  • Table 8: Sutures - Pipeline Products by Stage of Development 14
  • Table 9: Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 10: Additional PLUS Barbed Suture - Product Status 15
  • Table 11: Additional PLUS Barbed Suture - Product Description 15
  • Table 12: VICRYL - Next Gen - Product Status 16
  • Table 13: VICRYL - Next Gen - Product Description 16
  • Table 14: Vicryl Rapide Plus Suture - Product Status 16
  • Table 15: Vicryl Rapide Plus Suture - Product Description 17
  • Table 16: Ethicon US LLC - Ongoing Clinical Trials Overview 18
  • Table 17: Vicryl Rapide Plus Suture - Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section: A Randomized Controlled Study 19
  • Table 18: VICRYL - Next Gen - Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section: A Randomized Controlled Study 20
  • Table 19: Innovation Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 20: Antimicrobial Suture - Product Status 21
  • Table 21: Antimicrobial Suture - Product Description 21
  • Table 22: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 23: Drug-Loaded Microfiber Suture - Product Status 22
  • Table 24: Drug-Loaded Microfiber Suture - Product Description 22
  • Table 25: MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 26: CollaFix Collagen Fiber Suture - Product Status 23
  • Table 27: CollaFix Collagen Fiber Suture - Product Description 23
  • Table 28: Nobles Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 29: SuperStitch II - Product Status 24
  • Table 30: SuperStitch II - Product Description 24
  • Table 31: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 32: NuSpun Arteriovenous Suture - Product Status 25
  • Table 33: NuSpun Arteriovenous Suture - Product Description 25
  • Table 34: Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 35: RESOCAT CHROM SUTURE - Product Status 26
  • Table 36: RESOCAT CHROM SUTURE - Product Description 26
  • Table 37: RESOCAT PLAIN - Product Status 27
  • Table 38: RESOCAT PLAIN - Product Description 27
  • Table 39: SUPRAMID EXTRA SUTURE - Product Status 27
  • Table 40: SUPRAMID EXTRA SUTURE - Product Description 28
  • Table 41: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 42: Galvanis Suture - Product Status 29
  • Table 43: Galvanis Suture - Product Description 29
  • Table 44: Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 45: TephaFLEX Absorbable Multifilament Fiber - Product Status 30
  • Table 46: TephaFLEX Absorbable Multifilament Fiber - Product Description 30
  • Table 47: The University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 48: Angiogenic Suture - Product Status 31
  • Table 49: Angiogenic Suture - Product Description 31
  • Table 50: TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 51: ELUTE Fiber - Smart Suture - Product Status 32
  • Table 52: ELUTE Fiber - Smart Suture - Product Description 32
  • Table 53: VitaThreads, LLC Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 54: VitaSuture Wound Management System - Product Status 33
  • Table 55: VitaSuture Wound Management System - Product Description 33
  • Table 56: Glossary 100

List of Figures

1.2 List of Figures

  • Figure 1: Surgical Sutures - Pipeline Products by Stage of Development 7
  • Figure 2: Surgical Sutures - Pipeline Products by Segment 8
  • Figure 3: Surgical Sutures - Pipeline Products by Territory 9
  • Figure 4: Surgical Sutures - Pipeline Products by Regulatory Path 10
  • Figure 5: Surgical Sutures - Pipeline Products by Estimated Approval Date 11
  • Figure 6: Surgical Sutures - Ongoing Clinical Trials 12
Back to Top